This article is more than 5 years old. Information may no longer be current.

ESCRS calls for more multinational trials, pledges funding

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LISBON, Portugal — The European Society of Cataract and Refractive Surgeons will promote the undertaking of multinational European clinical studies by providing funds for research at an international group of clinical centers, an organization official announced

Jose Cunha-Vaz, MD, past president of the ESCRS, outlined progress in this effort at this year’s annual ESCRS meeting.

“We need to have more joint projects within the European Union,” he said.

Currently, a conglomerate of 15 clinical sites in Belgium, France, Germany, Greece, Italy, the Netherlands, Portugal, Spain and the United Kingdom have agreed to share information about ongoing clinical trials, all of which will be funded by the ESCRS, he said. Trials will be concentrated in four major clinical research areas: optics, surgical healing and inflammation, imaging and biomaterials, tissue engineering and drug delivery.

The goal of the joint undertaking, he said, is to “create an active area of research” in the European Union.